UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 27

Sortiert nach

Therapeutic Challenges to Retinitis Pigmentosa: From Neuroprotection to Gene Therapy

Current genomics, 2011-06, Vol.12 (4), p.276-284

2011

Volltextzugriff (PDF)

A randomised controlled trial to assess the clinical effectiveness and cost-effectiveness of alternative treatments to Inhibit VEGF in Age-related choroidal Neovascularisation (IVAN)

Health technology assessment (Winchester, England), 2015-10, Vol.19 (78), p.1-298

2015

Volltextzugriff (PDF)

Real-World Safety and Effectiveness of Voretigene Neparvovec: Results up to 2 Years from the Prospective, Registry-Based PERCEIVE Study

Biomolecules (Basel, Switzerland), 2024-01, Vol.14 (1), p.122

2024

Volltextzugriff (PDF)

Artificial Intelligence-Based Disease Activity Monitoring to Personalized Neovascular Age-Related Macular Degeneration Treatment: A Feasibility Study

Ophthalmology science (Online), 2024-11, Vol.4 (6), p.100565, Article 100565

2024

Volltextzugriff (PDF)

Accuracy of a Machine-Learning Algorithm for Detecting and Classifying Choroidal Neovascularization on Spectral-Domain Optical Coherence Tomography

Journal of personalized medicine, 2021-06, Vol.11 (6), p.524

2021

Volltextzugriff (PDF)

Value of anti-VEGF treatment in choroidal neovascularization associated with autosomal recessive bestrophinopathy

Digital journal of ophthalmology, 2013, Vol.19 (4), p.59-63

2013

Volltextzugriff (PDF)

Early multifocal electroretinogram findings during intravitreal ranibizumab treatment for neovascular age-related macular degeneration

Investigative ophthalmology & visual science, 2011-06, Vol.52 (6), p.3446-3451

2011

Volltextzugriff (PDF)

Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration: The STAIRWAY Phase 2 Randomized Clinical Trial

JAMA ophthalmology, 2020-09, Vol.138 (9), p.964

2020

Volltextzugriff (PDF)

Simultaneous Inhibition of Angiopoietin-2 and Vascular Endothelial Growth Factor-A with Faricimab in Diabetic Macular Edema: BOULEVARD Phase 2 Randomized Trial

Ophthalmology (Rochester, Minn.), 2019-08, Vol.126 (8), p.1155

2019

Volltextzugriff (PDF)

Safety and Efficacy of Different Doses and Regimens of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration: The AVENUE Phase 2 Randomized Clinical Trial

JAMA ophthalmology, 2020-09, Vol.138 (9), p.955

2020

Volltextzugriff (PDF)

326-OR: Faricimab for Diabetic Macular Edema: A Novel Anti–Angiopoietin-2/Anti–Vascular Endothelial Growth Factor Bispecific Antibody in Clinical Trials

Diabetes (New York, N.Y.), 2020-06, Vol.69 (Supplement_1)

2020

Volltextzugriff (PDF)

QUANTITATIVE ASSESSMENT OF AUTOMATED OPTICAL COHERENCE TOMOGRAPHY IMAGE ANALYSIS USING A HOME-BASED DEVICE FOR SELF-MONITORING NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

Retina (Philadelphia, Pa.), 2023-03, Vol.43 (3), p.433

2023

Volltextzugriff (PDF)

Bilateral severe fibrinous anterior uveitis--an unusual complication of pamidronate therapy exacerbated by topical latanoprost

Journal of ocular pharmacology and therapeutics, 2007-10, Vol.23 (5), p.513

2007

Volltextzugriff (PDF)

Computerized Assessment of Intraretinal and Subretinal Fluid Regions in Spectral-Domain Optical Coherence Tomography Images of the Retina

American journal of ophthalmology, 2013-02, Vol.155 (2), p.277-286.e1

2013

Volltextzugriff (PDF)

Epimacular brachytherapy for previously treated neovascular age-related macular degeneration: month 36 results of the MERLOT randomised controlled trial

British journal of ophthalmology, 2023-07, Vol.107 (7), p.987

2023

Volltextzugriff (PDF)

Polypoidal Choroidal Vasculopathy Masquerading as Neovascular Age-Related Macular Degeneration Refractory to Ranibizumab

American journal of ophthalmology, 2010-11, Vol.150 (5), p.666-673

2010

Volltextzugriff (PDF)

Novel pathogenic mutations in C1QTNF5 support a dominant negative disease mechanism in late-onset retinal degeneration

Scientific reports, 2017-09, Vol.7 (1), p.12147-15, Article 12147

2017

Volltextzugriff (PDF)

Phase I Trial of Anti–Vascular Endothelial Growth Factor/Anti-angiopoietin 2 Bispecific Antibody RG7716 for Neovascular Age-Related Macular Degeneration

Ophthalmology retina, 2017-11, Vol.1 (6), p.474-485

2017

Volltextzugriff (PDF)

Simultaneous Inhibition of Angiopoietin-2 and Vascular Endothelial Growth Factor-A with Faricimab in Diabetic Macular Edema

Ophthalmology (Rochester, Minn.), 2019-08, Vol.126 (8), p.1155-1170

2019

Volltextzugriff (PDF)

Distal arthrogryposis type IIB: Unreported ophthalmic findings

American journal of medical genetics, 2004-05, Vol.127A (1), p.35-39

2004

Volltextzugriff (PDF)

Effectiveness of ranibizumab for neovascular age-related macular degeneration using clinician-determined retreatment strategy

British journal of ophthalmology, 2011-04, Vol.95 (4), p.530-533

2011

Volltextzugriff (PDF)

Argon laser and trichiasis: a helpful tip

British journal of ophthalmology, 2001-06, Vol.85 (6), p.761-761

2001

Volltextzugriff (PDF)

Optical coherence tomography analysis of bilateral end-stage choroidal neovascularization where one eye is treated with photodynamic therapy

Clinical & experimental ophthalmology, 2007-01, Vol.35 (1), p.13-17

2007

Volltextzugriff (PDF)

Argon laser and trichiasis: a helpful tip

British journal of ophthalmology, 2001-06, Vol.85 (6), p.761-761

2001

Volltextzugriff (PDF)

Optical Coherence Tomography : A New Imaging Technique for Neovascular Age-Related Macular Degeneration

Sahni, Jayashree Nair

2008

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(21)

Publikationsform

Sprache

Englisch
(27)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(19)
Life Sciences & Biomedicine
(18)
Humans
(17)
Ophthalmology
(15)
Female
(14)
Male
(12)
Aged
(10)
Middle Aged
(10)
Macular Degeneration
(9)
Aged, 80 And Over
(8)
Retina
(8)
Vascular Endothelial Growth Factor
(7)
Age
(6)
Clinical Trials
(6)
Diabetic Retinopathy
(6)
Intravitreal Injections
(6)
Macular Degeneration - Drug Therapy
(6)
Choroidal Neovascularization - Drug Therapy
(5)
Medical Imaging
(5)
Patients
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Therapeutic Challenges to Retinitis Pigmentosa: From Neuroprotection to Gene Therapy

A randomised controlled trial to assess the clinical effectiveness and cost-effectiveness of alternative treatments to Inhibit VEGF in Age-related choroidal Neovascularisation (IVAN)

Real-World Safety and Effectiveness of Voretigene Neparvovec: Results up to 2 Years from the Prospective, Registry-Based PERCEIVE Study

Artificial Intelligence-Based Disease Activity Monitoring to Personalized Neovascular Age-Related Macular Degeneration Treatment: A Feasibility Study

Accuracy of a Machine-Learning Algorithm for Detecting and Classifying Choroidal Neovascularization on Spectral-Domain Optical Coherence Tomography

Value of anti-VEGF treatment in choroidal neovascularization associated with autosomal recessive bestrophinopathy

Early multifocal electroretinogram findings during intravitreal ranibizumab treatment for neovascular age-related macular degeneration

Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration: The STAIRWAY Phase 2 Randomized Clinical Trial

Simultaneous Inhibition of Angiopoietin-2 and Vascular Endothelial Growth Factor-A with Faricimab in Diabetic Macular Edema: BOULEVARD Phase 2 Randomized Trial

Safety and Efficacy of Different Doses and Regimens of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration: The AVENUE Phase 2 Randomized Clinical Trial

326-OR: Faricimab for Diabetic Macular Edema: A Novel Anti–Angiopoietin-2/Anti–Vascular Endothelial Growth Factor Bispecific Antibody in Clinical Trials

QUANTITATIVE ASSESSMENT OF AUTOMATED OPTICAL COHERENCE TOMOGRAPHY IMAGE ANALYSIS USING A HOME-BASED DEVICE FOR SELF-MONITORING NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

Bilateral severe fibrinous anterior uveitis--an unusual complication of pamidronate therapy exacerbated by topical latanoprost

Computerized Assessment of Intraretinal and Subretinal Fluid Regions in Spectral-Domain Optical Coherence Tomography Images of the Retina

Epimacular brachytherapy for previously treated neovascular age-related macular degeneration: month 36 results of the MERLOT randomised controlled trial

Polypoidal Choroidal Vasculopathy Masquerading as Neovascular Age-Related Macular Degeneration Refractory to Ranibizumab

Novel pathogenic mutations in C1QTNF5 support a dominant negative disease mechanism in late-onset retinal degeneration

Phase I Trial of Anti–Vascular Endothelial Growth Factor/Anti-angiopoietin 2 Bispecific Antibody RG7716 for Neovascular Age-Related Macular Degeneration

Simultaneous Inhibition of Angiopoietin-2 and Vascular Endothelial Growth Factor-A with Faricimab in Diabetic Macular Edema

Distal arthrogryposis type IIB: Unreported ophthalmic findings

Effectiveness of ranibizumab for neovascular age-related macular degeneration using clinician-determined retreatment strategy

Argon laser and trichiasis: a helpful tip

Optical coherence tomography analysis of bilateral end-stage choroidal neovascularization where one eye is treated with photodynamic therapy

Argon laser and trichiasis: a helpful tip

Optical Coherence Tomography : A New Imaging Technique for Neovascular Age-Related Macular Degeneration

Suchergebnisse filtern